Decreased striatal dopaminergic responsiveness in detoxified cocaine- dependent subjects

Nature

Volumn 386, Issue 6627, 1997, Pages 830-833

  Volkow, N D ^a,b   Wang, G J ^a   Fowler, J S ^a   Logan, J ^b   Gatley, S J ^a   Hitzemann, R ^b   Chen, A D ^a   Dewey, S L ^a   Pappas, N ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG DEPENDENCE; DRUG DETOXIFICATION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030891225     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/386830a0     Document Type: Article

References (30)

1. Koob, G. F. & Bloom, F. E. Cellular and molecular mechanism of drug dependence. Science 242, 715-723 (1988).
2. Di Chiara, G. & Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274-5278 (1988).
3. Volkow, N. D. et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch. Gen. Psychiatry 52, 456-463 (1995).
4. Dackis, C. A. & Gold, M. S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci. Biobehav. 9, 469-477 (1985).
5. Seeman, P., Guan, H. C. & Niznik, H. B. Endogenous dopamine lowers the dopamine D2 receptor density as measured by 3H raclopride: implications for positron emission tomography of the human brain. Synapse 3, 96-97 (1996).
6. 11C]raclopride in the human brain. Synapse 16, 255-262 (1994).
7. Bergman, J., Madras, B. K., Johnson, S. E. & Spealman, R. D. Effects of cocaine and related drugs in nonhuman primates: III, Self administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251, 150-155 (1989).
8. Wang, G.-J. et al. Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur. Addiction Res. 3, 49-54 (1997).
9. 11C raclopride binding in the human brain. J. Nucl. Med. 34, 609-613 (1993).
10. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13, 350-356 (1993).
11. Gifford, A., Gatley, S. J. & Ashby, C. R. Endogenously released dopamine inhibits the binding of dopaminergic PET and SPECT ligands in superfused rat striatal slices. Synapse 22, 232-238 (1996).
12. Wang, G.-J, et al. Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in human brain. Synapse 15, 246-249 (1993).
13. Youssef, K. et al. Inhibition of extrastriatal dopamine receptors by haloperidol. Synapse 19, 14-17 (1995).
14. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J. Cereb. Blood Flow Metab. 14, 995-1010 (1994).
15. Pontieri, F. E., Tanda, G., Orzi, F. & Di Chiara, G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382 255-257 (1996).
16. Robinson, T. E. & Berridge, K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291 (1993).
17. Brown, E. E., Robertson, G. S. & Fibiger, H. C. Evidence for conditioned neuronal activation following exposure to a cocaine paired environment: role of forebrain limbic structures. J. Neurosci. 12, 4112-4121 (1992).
18. Wang, G.-J. et al. Comparison of two PET radioligands for imaging extrastriatal dopamine transporters in human brain. Life Sci. 57, 187-191 (1995).
19. Madras, B. K. & Kaufman, M. J. Cocaine accumulates in dopamine-rich regions of primate brain after iv administration: comparison with mazindol distribution. Synapse 18, 261-275 (1994).
20. Shyu, B. C., Kiritsy-Roy, J. A., Morrow, T. J. & Casey, K. L. Neurophysiological and behavioral evidence for medial thalamic mediation of cocaine-induced dopaminergic analgesia. Brain Res. 572, 216-223 (1992).
21. Groenewegen, H. J. Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience 24, 379-431 (1988).
22. Nauta, W. J. H. The problem of the frontal lobe: a reinterpretation. J. Psychiatric Res. 8, 167-189 (1971).
23. McAlonan, G. M., Robbins, T. W. & Everitt, B. J. Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes. Neuroscience 52, 605-620 (1993).
24. Kolb, B. Studies on the caudate putamen and the dorsomedial thalamic nucleus: implications for mammalian frontal lobe function. Physiol. Behav. 18, 237-244 (1977).
25. Insel, T. R. Towards a neuroanatomy of obsessive-compulsive disorder. Arch. Gen. Psychiatry 49, 739-744 (1992).
26. Volkow, N. D. et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14, 169-177 (1993).
27. Modell, J. G., Mountz, J. M. & Beresford, T. P. Basal ganglia/limbic striatal and thalamocortical involvement in craving and loss of control in alcoholism. J. Neuropsychiatry 2, 123-144 (1990).
28. Volkow, N. D. et al. Evaluation of the human brain dopamine system with PET. J. Nucl. Med. 37, 1242-1256 (1996).
29. Gawin, F. & Kleber, H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry 43, 107-113 (1986).
30. 11C-methyl]-(1)-cocaine: PET studies in human subjects. J. Cereb. Blood Flow Metab. 10, 740-747 (1990).